Private Equity Portfolio Company
Alnylam Pharmaceuticals
Cambridge, Massachusetts
United States
https://www.alnylam.com
Alnylam (NASDAQ: ALNY) is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi....
Private Equity Owner: Polaris Partners
Acquisition Criteria
Investment Date:
Exit Date:
Status:
Add-on Acquisitions:
Industry (NAICS Code):
Testimonials
Become the next customer to share a success story about Private Equity Info's impact.
"Private Equity Info is critical to nearly every aspect of our role as an investment bank. We use it almost every day and the return on investment is clear."
Investment Banker
Bob McCormack
"PEI is superior for our sales team. It cuts to the core. It’s the sweet spot in terms of what you’re paying and what you’re getting.”
Advisory Firm